Master of Cancer Care Program, School of Health Sciences, Saint Francis University, United States; Cardiology Division, Veterans Affairs Palo Alto Health Care System/Stanford University, United States.
Cardiology Division, Veterans Affairs Palo Alto Health Care System/Stanford University, United States; Faculty of Physical Education, University of Brasília, Brazil.
J Sci Med Sport. 2019 Apr;22(4):403-407. doi: 10.1016/j.jsams.2018.10.002. Epub 2018 Oct 19.
To evaluate the association between cardiorespiratory fitness (CRF), lung cancer incidence and cancer mortality in men.
Prospective cohort study.
Maximal exercise testing was performed in 4920 men (59.2±11.4years) free from malignancy at baseline. Multivariate Cox hazard models adjusted for established cancer risk factors including smoking were analyzed for lung cancer incidence and cancer mortality among those who were diagnosed with lung cancer. Population attributable risks (PAR) of low CRF (<5 METs) were determined.
During 12.7±7.5years follow-up, 105 (2.1%) participants were diagnosed with lung cancer and 83 (79%) of those died from cancer after 3.6±4.6 years from diagnosis. CRF was inversely and independently associated with cancer outcomes. A 1-MET increase and categories of moderate and high CRF were associated with 10%, 47% and 65% reduction in lung cancer incidence (p=0.002), and 13%, 58% and 76% reduction in cancer mortality (p=0.002), respectively. Also, individuals who were diagnosed with lung cancer and were at moderate or high CRF categories at baseline exhibited longer survival time (p<0.001). The PARs% for lung cancer incidence and cancer mortality were 8.7% and 18.5%, respectively.
Higher CRF is associated with lower lung cancer incidence in men. Among individuals who were diagnosed with lung cancer, higher CRF was associated with reduced cancer mortality and longer survival time. These results support the protective benefits of higher CRF in the prevention of lung cancer outcomes. Eliminating low CRF as a risk factor would potentially prevent considerable lung cancer morbidity and mortality.
评估心肺适能(CRF)与男性肺癌发病率和癌症死亡率之间的关联。
前瞻性队列研究。
在基线时,对 4920 名(59.2±11.4 岁)无恶性肿瘤的男性进行最大运动测试。对经过多变量 Cox 风险模型调整的包括吸烟在内的既定癌症风险因素进行分析,以评估肺癌发病率和癌症死亡率。确定低 CRF(<5 METs)的人群归因风险(PAR)。
在 12.7±7.5 年的随访期间,105 名(2.1%)参与者被诊断患有肺癌,其中 83 名(79%)在诊断后 3.6±4.6 年后死于癌症。CRF 与癌症结局呈负相关且独立相关。CRF 每增加 1 个单位和中等及高 CRF 类别与肺癌发病率降低 10%、47%和 65%相关(p=0.002),癌症死亡率降低 13%、58%和 76%相关(p=0.002)。此外,在基线时被诊断患有肺癌且处于中等或高 CRF 类别的个体的生存时间更长(p<0.001)。肺癌发病率和癌症死亡率的 PARs%分别为 8.7%和 18.5%。
较高的 CRF 与男性肺癌发病率降低相关。在被诊断患有肺癌的个体中,较高的 CRF 与降低癌症死亡率和延长生存时间相关。这些结果支持更高 CRF 在预防肺癌结果方面的保护作用。消除低 CRF 作为一个风险因素可能会显著预防肺癌发病率和死亡率。